Cite
HARVARD Citation
Goldberg, A. et al. (2020). Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study. Leukemia research. p. . [Online].